The Global Summit on Vaccines, Immunology & Public Health 2026 advances global knowledge on vaccines, immunology, and public health, highlighting innovations in vaccine development, delivery, and policy.
Key Topics
- mRNA vaccines and applications
- Viral vector-based vaccines
- DNA vaccines: progress and challenges
- Peptide and protein-based vaccines
- Nanotechnology in vaccine delivery
- Novel vaccine adjuvants and immunopotentiators
- Combination and multivalent vaccines
- Vaccine formulation and stability
- Innate and adaptive immune mechanisms
- Immunogenetics and vaccine response
- Immunoinformatics in vaccine design
- Autoimmunity and vaccination
- Immune system aging and vaccine efficacy
- Mucosal immunity and oral vaccines
- T-cell and B-cell immunity in vaccination
- Immune evasion mechanisms of pathogens
- Immunoengineering and synthetic immunology
- Cold chain and logistics in vaccine distribution
- One Health approach to zoonotic diseases
- Behavioral science in vaccine uptake
- Vaccines against respiratory viruses
- Media and misinformation in public health
- Lessons learned from COVID-19 vaccine trials
- Immunotoxicology and safety evaluation
- Predictive modelling of epidemics and pandemic preparedness
- Health economics of vaccination programs
- Regulatory affairs and vaccine approvals
- Surveillance and monitoring of vaccine-preventable diseases
- Global immunization programs and policies
- Phase I–IV vaccine trials: insights and outcomes
- Ethical issues in vaccine testing
- Community engagement and vaccine literacy
- 3D-bioprinting for immunological models
- Herd immunity in vulnerable populations
- Vaccines in pregnancy: benefits and barriers
- Emerging zoonoses and vector-borne diseases
- Vaccine hesitancy and public perception
- Pandemic preparedness and response strategies
- Antimicrobial resistance and vaccine role
- Vaccine development for bioterrorism threats
- Training and capacity building in immunology
- CRISPR and genomics in vaccine R&D
- Systems biology in vaccine research
- Hepatitis vaccines: advances and challenges
- Data-driven modelling in vaccines and public health
- Maternal immunization for neonatal protection
- Real-world evidence and post-market surveillance
- Role of NGOs in immunization programs
- Artificial intelligence in vaccine discovery
- HIV, tuberculosis, and malaria vaccine development
- Vaccine access and equity in low-resource settings
- Epidemiological models for vaccine development and policy
- AI and big data in epidemiological forecasting
- Science communication in vaccine awareness
- Blockchain in vaccine supply chain management
- Vaccine clinical trial design and implementation
- Geriatric vaccines and immune senescence
- Personalized vaccinology and precision medicine
- Mathematical modelling in infectious disease dynamics
- Organoids and in-vitro models for vaccine testing
- Childhood immunization strategies
- Adolescent immunization coverage
Who should Attend
- Vaccine researchers and immunologists
- Public health professionals and epidemiologists
- Medical and clinical trial specialists
- Regulatory and policy experts in immunization
- Pharmaceutical and biotech industry representatives
- Healthcare providers and clinicians
- NGOs and global health organizations
- Data scientists and AI specialists in health
- Academics and students in immunology and public health
- Community engagement and science communication professionals
- Biotechnology and vaccine delivery innovators
- Healthcare program managers and planners
- Ethics and safety evaluators in clinical research
